Alcon
ALC Healthcare Medical Instruments & Supplies
Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS fell 100.0%, free cash flow was flat and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow ALC
Alcon (ALC) P/E ratio
As of 16 October 2026, Alcon (ALC) trades at a P/E ratio of 50.5×. Over the past ten years it has ranged from 0.0× (June 2021) to 236× (September 2021); the current reading is higher than 68% of that period. That is above the Medical Instruments & Supplies industry median of 33.8× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 39.6× | (4.36%) |
| FY2024 | 41.4× | 5.89% |
| FY2023 | 39.1× | (61.45%) |
| FY2022 | 101× | (11.03%) |
| FY2021 | 114× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 21.7× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 51.2× | 13.52% |
| Mar 2026 | 45.1× | 13.93% |
| Dec 2025 | 39.6× | 12.68% |
| Sep 2025 | 35.1× | (13.61%) |
| 28 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BAX Baxter International Inc. compare | n/m |
| SOLV Solventum Corporation compare | 10.4× |
| COO The Cooper Companies, Inc. compare | 19.8× |
| RMD ResMed Inc. compare | 22.8× |
| WST West Pharmaceutical Services, Inc. compare | 48.7× |
| ALC Alcon | 50.5× |
| BDX Becton, Dickinson and Company compare | 57.8× |
| RGEN Repligen Corporation compare | 234× |
| MDLN Medline Inc. compare | — |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)